Correlation Between Alnylam Pharmaceuticals and Incyte
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Incyte, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Incyte.
Diversification Opportunities for Alnylam Pharmaceuticals and Incyte
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Alnylam and Incyte is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Incyte go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Incyte
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 2.28 times more return on investment than Incyte. However, Alnylam Pharmaceuticals is 2.28 times more volatile than Incyte. It trades about 0.25 of its potential returns per unit of risk. Incyte is currently generating about 0.24 per unit of risk. If you would invest 23,531 in Alnylam Pharmaceuticals on November 1, 2024 and sell it today you would earn a total of 3,868 from holding Alnylam Pharmaceuticals or generate 16.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. Incyte
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| Incyte |
Alnylam Pharmaceuticals and Incyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and Incyte
The main advantage of trading using opposite Alnylam Pharmaceuticals and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
| Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |